Response to: Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'.
作者信息
Shin Vivian Y, Kwong Ava
机构信息
Department of Surgery, The University of Hong Kong, Hong Kong, SAR.
The Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong, SAR.
出版信息
Br J Cancer. 2016 May 10;114(10):e6. doi: 10.1038/bjc.2016.2. Epub 2016 Apr 21.
Abstract
摘要
相似文献
1
Response to: Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'.对《关于循环游离微小RNA作为三阴性乳腺癌生物标志物的评论》的回应
Br J Cancer. 2016 May 10;114(10):e6. doi: 10.1038/bjc.2016.2. Epub 2016 Apr 21.
2
Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'-Methodological challenges in combining miRNAs as circulating biomarkers.关于“循环游离微小RNA作为三阴性乳腺癌生物标志物”的评论——将微小RNA作为循环生物标志物进行组合时的方法学挑战。
Br J Cancer. 2016 May 10;114(10):e5. doi: 10.1038/bjc.2016.1. Epub 2016 Apr 21.
3
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.鉴定miR-10b、miR-26a、miR-146a和miR-153作为潜在的三阴性乳腺癌生物标志物。
Cell Oncol (Dordr). 2015 Dec;38(6):433-42. doi: 10.1007/s13402-015-0239-3. Epub 2015 Sep 21.
4
Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.在沙特女性乳腺癌患者的血浆中检测到肿瘤抑制 miRNA let-7 和 miR-195 的稳健表达。
BMC Cancer. 2017 Nov 28;17(1):799. doi: 10.1186/s12885-017-3776-5.
5
miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers.miR-10b、miR-26a、miR-146a和miR-153在三阴性与非三阴性乳腺癌中的表达：潜在生物标志物
Pathol Oncol Res. 2017 Oct;23(4):815-827. doi: 10.1007/s12253-017-0188-4. Epub 2017 Jan 18.
6
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.miR-105/93-3p 促进化疗耐药，循环 miR-105/93-3p 可作为三阴性乳腺癌的诊断生物标志物。
Breast Cancer Res. 2017 Dec 19;19(1):133. doi: 10.1186/s13058-017-0918-2.
7
MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.三阴性乳腺癌中MicroRNA失调揭示了miR-498在调节BRCA1表达中的作用。
Oncotarget. 2016 Apr 12;7(15):20068-79. doi: 10.18632/oncotarget.7705.
8
MicroRNAs as regulatory elements in triple negative breast cancer.微小RNA作为三阴性乳腺癌中的调控元件
Cancer Lett. 2014 Nov 1;354(1):1-4. doi: 10.1016/j.canlet.2014.07.036. Epub 2014 Aug 10.
9
MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.微小RNA-148a具有抑制转移的功能，并可作为三阴性乳腺癌的预后指标。
Oncotarget. 2016 Apr 12;7(15):20381-94. doi: 10.18632/oncotarget.7953.
10
miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.miR-629-3p可能作为三阴性乳腺癌肺转移的一种新型生物标志物和潜在治疗靶点。
Breast Cancer Res. 2017 Jun 19;19(1):72. doi: 10.1186/s13058-017-0865-y.
引用本文的文献
1
miRNA Expression Profiles in Luminal A Breast Cancer-Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment.腔面 A 型乳腺癌中的 miRNA 表达谱——对生物学、预后和激素治疗反应预测的影响。
Int J Mol Sci. 2020 Oct 17;21(20):7691. doi: 10.3390/ijms21207691.
本文引用的文献
1
Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort Study.一项预测前列腺癌复发和转移的五个微小RNA特征的鉴定与验证：队列研究
J Cancer. 2015 Sep 15;6(11):1160-71. doi: 10.7150/jca.13397. eCollection 2015.
2
A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.一种循环miRNA特征作为乳腺癌非侵入性早期检测的诊断生物标志物。
Breast Cancer Res Treat. 2015 Nov;154(2):423-34. doi: 10.1007/s10549-015-3591-0. Epub 2015 Oct 17.
3
Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.下一代测序分析确定miR-574-3p和miR-660-5p为乳腺癌潜在的新型预后标志物。
BMC Genomics. 2015 Sep 29;16:735. doi: 10.1186/s12864-015-1899-0.
4
Circulating cell-free miRNAs as biomarker for triple-negative breast cancer.循环游离微小RNA作为三阴性乳腺癌的生物标志物
Br J Cancer. 2015 May 26;112(11):1751-9. doi: 10.1038/bjc.2015.143. Epub 2015 Apr 23.
5
Solid tumors of childhood display specific serum microRNA profiles.儿童实体瘤呈现出特定的血清微小RNA谱。
Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):350-60. doi: 10.1158/1055-9965.EPI-14-0669. Epub 2014 Nov 21.
6
An integrated mRNA and microRNA expression signature for glioblastoma multiforme prognosis.一种用于多形性胶质母细胞瘤预后的整合mRNA和微小RNA表达特征。
PLoS One. 2014 May 28;9(5):e98419. doi: 10.1371/journal.pone.0098419. eCollection 2014.
7
Statistical evaluation of a biomarker.生物标志物的统计学评估
Anesthesiology. 2010 Apr;112(4):1023-40. doi: 10.1097/ALN.0b013e3181d47604.
Zotero 插件